CJC-1295 (DAC)
GHRH Analogue with Drug Affinity Complex
CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH) with Drug Affinity Complex technology extending its plasma half-life. Commonly researched in GH secretagogue studies.
Ipamorelin
Selective GH Secretagogue
Ipamorelin is a pentapeptide and selective growth hormone secretagogue (GHS). Widely used in research exploring GH pulse amplitude without cortisol or prolactin stimulation.
IGF-1 LR3
Long Arg3 IGF-1
IGF-1 LR3 is a synthetic analogue of IGF-1 with an arginine substitution and N-terminal extension, resulting in significantly reduced binding protein affinity and an extended in vitro half-life.
Hexarelin
Examorelin
Hexarelin is a synthetic hexapeptide analogue of GHRP-6 and potent GHS-R1a agonist. Used in research exploring GH secretion dynamics and cardiac function models.
CJC-1295 (No DAC)
Modified GRF (1-29)
CJC-1295 without DAC (also known as Modified GRF 1-29) is a truncated analogue of GHRH with a shorter half-life than the DAC version. Frequently used in pulsatile GH release research protocols.
Sermorelin
GHRH (1-29) Analogue
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous GHRH. Studied as a GH secretagogue in research models examining pituitary somatotroph responsiveness and GH pulse dynamics.
Tesamorelin
Trans-3-Hexenoic Acid-GHRH Analogue
Tesamorelin is a stabilized analogue of GHRH conjugated with trans-3-hexenoic acid to improve plasma stability. Studied for GH secretion stimulation in adipose tissue redistribution research models.